BLVRA and Alzheimer disease: Moreover, another study reports that in plasma of probable AD patients, both HO-1 and biliverdin reductase (BVR) levels are increased as a consequence of the enhanced oxidative stress, and plasma BVR status, more than HO-1, is proposed as potential biochemical marker for the prediction of AD at the earliest stages of disease [135].